Dustin Sulak, DO, Healer.com, Dustin Sulak, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis, the author of the first foundational text on its clinical use, Handbook of Cannabis for Clinicians: Principles and Practice, and a co-founder of Healer.com, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis, and serves on the board of directors of The Society of Cannabis Clinicians.

Ethan B. Russo, MD, CreDO Science , Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and
author. He is the Founder and CEO of CReDo Science www.credo-science.com

Previously, he was Director of Research and Development of the International Cannabis
and Cannabinoids Institute (ICCI) based in Prague, Czech Republic:
https://www.icci.science. Medical Director of PHYTECS (2015-2017), a biotechnology
company researching and developing innovative approaches targeting the human
endocannabinoid system (http://www.phytecs.com), and from 2003-2014, he served as
Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals,
United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of
cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex®
for intractable epilepsy (https://www.gwpharm.com).

He graduated from the University of Pennsylvania (Psychology), and the University of
Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and
in Child and Adult Neurology at the University of Washington in Seattle. He was a
clinical neurologist in Missoula, Montana for 20 years in a practice with a strong chronic
pain component. In 1995, he pursued a 3-month sabbatical doing ethnobotanical research
with the Machiguenga people in Parque Nacional del Manu, Peru.

He has held faculty appointments in Pharmaceutical Sciences at the University of
Montana, in Medicine at the University of Washington, and as visiting professor, Chinese
Academy of Sciences, Harvard University, and Johns Hopkins University.

He is a Past-President of the International Cannabinoid Research Society and is former
Chairman of the International Association for Cannabinoid Medicines. He serves on the
Scientific Advisory Board for the American Botanical Council. He is author of
Handbook of Psychotropic Herbs, co-editor of Cannabis and Cannabinoids:
Pharmacology, Toxicology and Therapeutic Potential, and author of The Last Sorcerer:
Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics,
selections of which were published as books: Cannabis Therapeutics in HIV/AIDS,
Women and Cannabis: Medicine, Science and Sociology, Cannabis: From Pariah to
Prescription, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He
has also published numerous book chapters, and over sixty articles in neurology, pain
management, cannabis, and ethnobotany. His research interests have included
correlations of historical uses of cannabis to modern pharmacological mechanisms,
phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and
phytocannabinoid/terpenoid, serotonergic and vanilloid interactions.

He has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.

Gregory L. Gerdeman, Ph.D. , NASHCX , Dr. Greg Gerdeman is a neuroscientist, cannabinoid researcher and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS), as well as many facets of cannabis cultivation, extraction and medicinal use. His Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as so-called “retrograde messengers” that regulate synaptic plasticity in the brain. These findings have become a foundation to modern understanding of the ECS as well as the neuroprotective and neuromodulating properties of cannabis. His writings, reflections and other digital content can be found at DrGerdeman.com.

Allyn Howlett, PhD, Wake Forest School of Medicine, Dr. Howlett is an expert on cannabinoid receptors, and is noted for her discovery of the brain cannabinoid receptor that is stimulated by Tetrahydrocannabinol (THC), the psychoactive compound in cannabis extracts. Dr. Howlett has worked with academic and pharmaceutical company chemists to study how THC, and synthetic drugs that are based upon THC, work in the brain. She has been active in the International Cannabinoid Research Society, and served as president in 2009-2010. She is currently an Associate Editor of the journal “Cannabis and Cannabinoid Research”. Dr. Howlett’s research is supported by a grant from the National Institute on Drug Abuse.

Dr. Bridget Williams M.D. , Green Harvest Health , Dr. Bridget Williams is an established family physician for nearly 20 years. She is the owner of Green Harvest Health, a medical cannabis clinic as well as Cole-Williams Coaching & Consulting. Combined together, Green Harvest Health is the only medical cannabis clinic in Ohio with life and wellness coaching incorporated into the practice. Dr. Bridget found a need for a trusted CBD to recommend to her patients. This led to the development of GHH CBD Medicinals which is a collection of high quality, well tested CBD products. Dr. Williams has spent her career guiding patients and colleagues in one of the largest health systems in the country. Her desire is to help others build awareness and a better life. Dr. Williams provides valuable talks on medical cannabis, CBD and balanced wellness across Ohio as well as teaching at the Cleveland School of Cannabis. By working with Dr. Williams, your life-balance will be established and your confidence will soar. It is through self discovery that habits can be broken and significant changes can be made.

Todd A Scattini, Blue Diamond Ventures, Todd is the Chairman of the Board of Blue Diamond Ventures and Global CEO of Harvest 360 Technologies. Todd is a retired Army Lieutenant Colonel who was a leading voice in medical cannabis legalization in Missouri working with KC NORML. He is active in Kansas as an advisory board member with the Kansas Cannabis Coalition. Todd brings strong leadership, global vision, and strategic direction to the cannabis conversation and enjoys engaging with thought leaders across the space.

His energy is drawn from his passion for the cannabis plant and a deep-seeded desire to unpack all its possibilities to heal patients and our planet, legitimately contribute to a global economy, and bring social justice to our society. He is committed to creating an effective and responsible legal cannabis market on a global scale. Todd is a West Point graduate and brings with him vast experience gained during a distinguished military career serving in a broad range of leadership positions in complex domestic and international settings, including five years of diplomatic service. He is an expert at providing consultative assistance to senior leaders; developing and managing relationships with key decision makers; managing multiple complex projects simultaneously and communicating organizational goals and objectives. He has laid the groundwork for high impact in the rapidly emerging European markets.

Paul E. Callicoat, M.D., Sarcoxie Nursery , Paul E. Callicoat, M.D.
Paul@sarcoxienursery.com

Paul E. Callicoat, M.D. is a retired board-certified interventional cardiologist from Joplin, MO. A fellow emeritus of the American College of Cardiology and member of the Missouri Medical Association, Paul currently serves as president of MoFarma 21, LLC, Sarcoxie Nursery, LLC; and is a co-owner of Hops 21, LLC.
After receiving a B.S. in Biology and B.A. in Chemistry from the University of North Carolina Wilmington, Paul attended medical school at the University of North Carolina School of Medicine. From there, he received his internal medicine training at St. Luke’s Hospital in Kansas City and cardiology training at St. Louis University Hospital. Paul went on to build a career as an esteemed cardiologist in Joplin, MO, and Grove, OK—becoming one of the first physicians in the U.S. to own and operate his own interventional cardiac catheterization lab.
In 2014, Paul sold his catheterization lab and cardiology practice. Soon after retirement, he was introduced to the medical cannabis industry by his son, Jonathon. Together they have built a state-of-the-art cannabis growing facility where they are currently licensed by the Missouri Department of Agriculture as an indoor hemp cultivator. They continue to develop strains of CBD producing hemp.
Dr. Callicoat is actively involved with the progression of marijuana laws in the state of Missouri. He strongly believes in the plants safety profile and ability to help alleviate many somatic and psychological symptoms.

Jahan Marcu, PhD, Marcu & Arora, Dr. Jahan Marcu has over 15 years of experience in cannabinoid research, policy, and operations. He has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system, and the role of the ECS in bone). Dr. Marcu has published basic and clinical research, and is also trained in psilocybin assisted therapy. Dr. Marcu is a founding partner at the consulting firm of Marcu & Arora, which provides life science consulting to the cannabis and psychedelics fields.

Dr. Marcu’s work has been instrumental to facilitating and supporting fact-based, scientific approaches vital to industry and patients. This has included research focused on solving the structure and function of cannabinoid receptors, the anti-cancer properties of cannabis compounds, as well as method development and validation for analyzing complex formulations. Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia’s Cannabis Quality Control and Therapeutic Monographs, and assisting in the creation of the first standards for industry as a committee chairman of the cannabis committee for the American Herbal Products Association (AHPA). His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu co-authored one of the first product safety studies on CBD products.

He is also the founding Editor-In-Chief of the American Journal of Endocannabinoid Medicine. He is Adjunct Faculty at the University of the Sciences in Philadelphia, PA and teaches on the pharmacology of cannabis, regulation and finance for the cannabis industry, and other related subjects for pharmacists, health professionals and business majors. He is also founder and past-chair of the Cannabis Chemistry Sub-division of the American Chemical Society, the world’s largest and oldest professional scientific society. Further illustrating the recognition earned through his efforts, he has been asked to serve on multiple expert government advisory and trade association committees, as well as scientific organizations including ASTM (D37 Subcommittee chair), AHPA Cannabis committee (past-chair of laboratory sub-committee), ACS Cannabis Chemistry Subdivision (CANN), AOCS, AOAC, IACM(past BOD), and IMCPC (co-founder). He is also host and producer of the podcast, How to Launch an Industry.

Reflecting his dedication to the field, Dr. Marcu has received numerous awards including the Mahmoud Elsohly award for excellence in cannabis chemistry and the Billy Martin research achievement award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. He is also a court-qualified synthetic cannabinoid and cannabis expert. His work has been published and covered in publications such as Rolling Stone, Science, Nature, JAMA, the Washington Post, CNN, and many other media outlets.

Lisa Roark, MD, Roark Family Health, Cassville Dispensary, Dr. Lisa Roark received her combined BA/MD from University of Missouri-Kansas City. With over 15 years of medical experience, Dr. Roark practices in Southwest Missouri in all areas of Family Medicine, including pediatrics, women’s health, geriatrics, opiate addiction treatment, and medical marijuana physician certifications and patient management, where she is the sole owner and Medical Director of Roark Family Health.

Dr. Roark’s history as an advocate for medical marijuana education in Missouri, as well as an established community volunteer, led to the natural progression of becoming the sole owner of Cassville Dispensary, where she serves as CEO and Medical Director.

Dr. Roark lives in Cassville, MO with her husband and business partner, Griff. They have 4 beautiful children and enjoy boating, farming, hiking and yoga.

Tamara Netzel, Cruel Consequences Portraits of Misguided Law, Tamara Netzel Bio:

Awarded Cannabis Activist of the Year 2020 from Virginia NORML, and in the top 10 Who’s Who in Virginia Cannabis by District Fray Magazine, Tamara Netzel, a former middle school teacher who medically retired due to her Multiple Sclerosis, continues to educate communities to break the stigma of cannabis consumers and those who have been criminalized through her 501c3 nonprofit, Cruel Consequences: Portraits of Misguided Law. The growing portrait collection can be seen at cruelconsequences.org which is a collection of personal stories of people criminalized for cannabis, highlighting the collateral consequences of any cannabis charge leading to denial of employment, housing, child custody, college loans, and more well after court requirements are met. Netzel and her husband were featured on NBC Dateline in March 2017 for her testimony in the Virginia General Assembly for the unanimous vote on the medical cannabis law that opened up the state’s program to thousands of patients.

Cruel Consequences: Portraits of Misguided Law is a 501c3 national nonprofit portrait exhibit of people who have been harmed by marijuana prohibition. We take our traveling exhibit to community events and put these portraits in front of lawmakers and community leaders to break down the stigma and bring awareness of cannabis consumers who are prevented from pursuing their lives after a marijuana charge. Our portraits are also on the walls of 10 dispensaries across the U.S. to promote awareness of cannabis social justice alongside the growth of the cannabis industry in our Pursuit of Happiness Exhibit Program. Several Missouri cannabis businesses have our exhibits to include aliceCBD, Cassville Dispensary, and COCO Labs. Bass

April Hatch MSN, RN, Cannabis Care Team, April is a registered nurse with a Master’s in Public Health Nursing and has experience in acute care, public health, and education. As a member of multiple professional organizations, including the American Cannabis Nurses Association, the Society of Cannabis Clinicians, the Hospice & Palliative Nurses Association, and the American Holistic Nurses Association, she completed the first Medical Cannabis certificate program for healthcare professionals along with receiving hands-on training from Dr. Dustin Sulak in Maine. She is currently enrolled in the California Institute of Integral Studies Center for Psychedelic Therapies Certificate program. While education alone might illustrate April’s passion for plant medicine, her focus on cannabis began when her son suffered a traumatic brain injury and she saw the positive impact of cannabis in her son’s life. Over the past six years, April has been a tireless advocate for providing education, support, and advocacy to patients and the cannabis industry. Today, she serves in multiple capacities including the continuation of 1:1 patient consultations, developing and facilitating dispensary staff training, and her role teaching cannabis pharmacology at Saint Louis University. Despite wearing so many hats in the industry, April’s passion for educating others is what keeps her constantly moving forward and continuing to spread science-based evidence to the industry and patients at large.